Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US
Clinical trial NCT00617344 · COMPLETED
Trial details
- NCT number
- NCT00617344
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-17
- Primary completion
- 2009-12-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.